Susquehanna International Group, LLP Anixa Biosciences Inc Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 195,171 shares of ANIX stock, worth $485,975. This represents 0.0% of its overall portfolio holdings.
Number of Shares
195,171
Previous 281,693
30.71%
Holding current value
$485,975
Previous $698,000
20.06%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ANIX
# of Institutions
63Shares Held
5.48MCall Options Held
24.5KPut Options Held
23.4K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.47 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.55 Million0.29% of portfolio
-
D.A. Davidson & Co.614KShares$1.53 Million0.01% of portfolio
-
Ubs Group Ag524KShares$1.31 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.17 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $76.3M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...